Additionally, although the sIL-6R levels were unexpectedly lower in obese patients with T2DM than in the other groups of patients, there is the possibility that hyper-IL-6 was involved in the observed effects in obese patients with T2DM. Here, IL6R is linked to type 2 diabetes mellitus.